Literature DB >> 22512940

A new device expanding operability of fingertip replantation: subzone 1 fingertip replantation assisted by non-enhanced angiography in a 2-year-old boy.

Hidehiko Yoshimatsu1, Takumi Yamamoto, Yukio Seki, Mitsunaga Narushima, Takuya Iida, Isao Koshima.   

Abstract

Fingertip replantation in young children is difficult, especially in cases with amputation at subzone 1. Replantation is preferred whenever possible, but the identification of vessels of operative size can be very challenging. Non-enhanced angiography (NEA; Genial Viewer; Genial Light, Shizuoka, Japan) emits infrared light with the wavelength of 850 nm, which is exclusively absorbed by haemoglobin. The light penetrates the bones and other soft tissues, effectively visualising vessels containing blood, and the image is shown in real time on the screen of a laptop computer. We present a case in which preoperative NEA visualised vessels in the amputated fingertip, allowing a successful replantation in a 2-year-old boy. By taking the guesswork out of vessel localisation, NEA can be useful in expanding operability of replantation surgery in fingertip amputations.
Copyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22512940     DOI: 10.1016/j.bjps.2012.03.039

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  2 in total

1.  Cross-cultural variation in preference for replantation or revision amputation: Societal and surgeon views.

Authors:  Brianna L Maroukis; Melissa J Shauver; Takanobu Nishizuka; Hitoshi Hirata; Kevin C Chung
Journal:  Injury       Date:  2016-03-02       Impact factor: 2.586

2.  Transplantation of a Free Vascularized Joint Flap from the Second Toe for the Acute Reconstruction of Defects in the Thumb and other Fingers.

Authors:  Jihui Ju; Lei Li; Ruixing Hou
Journal:  Indian J Orthop       Date:  2019 Mar-Apr       Impact factor: 1.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.